Bessie Meechoovet

1.4k citations
13 papers · 784 indexed · h-index 12
Topics
Extracellular vesicles in disease (5 papers)Alzheimer's disease research and treatments (4 papers)Nuclear Receptors and Signaling (2 papers)

In The Last Decade

Bessie Meechoovet

13 papers receiving 774 citations

Peers

Bessie Meechoovet
Comparison fields: 5 of 86
  • Molecular Biology 507
  • Cancer Research 164
  • Physiology 159
  • Immunology 118
  • Pharmacology 81
Replace Pia Larssen with:
Pia Larssen Sweden
Xiangping Qu China
Gwënaël Pottiez France
Xavier Gallart‐Palau Singapore
Ruteja A. Barve United States
Parameswaran G. Sreekumar United States
Ching‐Chi Chiu Taiwan
Fei Lan China
Guimei Zhang China
Bessie Meechoovet relative to Pia Larssen Sweden Pia Larssen's profile →
Citations per field
00.5×1.5×
Pia Larssen · 1×
Citations per year

Countries citing papers authored by Bessie Meechoovet

Since Specialization
Citations

This map shows the geographic impact of Bessie Meechoovet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bessie Meechoovet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bessie Meechoovet more than expected).

Fields of papers citing papers by Bessie Meechoovet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bessie Meechoovet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bessie Meechoovet. The network helps show where Bessie Meechoovet may publish in the future.

Co-authorship network of co-authors of Bessie Meechoovet

This figure shows the co-authorship network connecting the top 25 collaborators of Bessie Meechoovet. A scholar is included among the top collaborators of Bessie Meechoovet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bessie Meechoovet. Bessie Meechoovet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 35
2 53
3 186
4 1
5 51
6 70
7 30
8 87
9 63
10 11
11 134
12 16
13 47

About Bessie Meechoovet

Bessie Meechoovet is a scholar working on Neurology, Immunology and Cellular and Molecular Neuroscience, having authored 13 papers that have together received 784 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), Alzheimer's disease research and treatments (4 papers) and Nuclear Receptors and Signaling (2 papers). The work is most often cited by research in Cancer Research (164 citations), Biological Psychiatry (21 citations) and Molecular Biology (507 citations). Bessie Meechoovet has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Travis Dunckley, Kendall Van Keuren‐Jensen, Tong Wang, Eric Alsop, Stephen Gately, Marco Giorgetti, Tuan Anh Phu, Laura Bouchareychas, Hiromitsu Nakauchi and Phat Duong. Their work appears in journals such as PLoS ONE, NeuroImage and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026